Functional characterization of α1-adrenoceptor subtypes in longitudinal and circular muscle of human vas deferens

European Journal of Pharmacology

Volumn 367, Issue 2-3, 1999, Pages 291-298

  Amobi, Nnaemeka ^a   Guillebaud, John ^b   Coker, Charles ^c   Mulvin, David ^c   Smith, I Christopher H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Margaret Pyke Centre   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Noradrenaline; Vas deferens, human; 1 Adrenoceptor subtype

Indexed keywords

8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR; CHLOROETHYLCLONIDINE; NORADRENALIN; PHENOXYBENZAMINE; PRAZOSIN; SPIPERONE; 5 METHYLURAPIDIL; 5-METHYLURAPIDIL; ADRENERGIC RECEPTOR; ALKYLATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DRUG DERIVATIVE; PIPERAZINE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG BINDING SITE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; VAS DEFERENS; ADULT; BINDING COMPETITION; CLASSIFICATION; DOSE RESPONSE; DRUG EFFECT; MALE; MIDDLE AGED; MUSCLE CONTRACTION; PHYSIOLOGY; SMOOTH MUSCLE;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; ALKYLATING AGENTS; BINDING, COMPETITIVE; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NOREPINEPHRINE; PHENOXYBENZAMINE; PIPERAZINES; PRAZOSIN; RECEPTORS, ADRENERGIC; SPIPERONE; VAS DEFERENS;

EID: 0032587893     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00989-3     Document Type: Article

References (42)

1. 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen. Br. J. Pharmacol. 109:1993;80-87.
2. Amobi N.I.B., Smith I.C.H. Effects of thioridazine on mechanical responses of human vas deferens induced by noradrenaline or potassium. J. Reprod. Fertil. 95:1992;1-10.
3. Amobi N., Smith I.C.H. The human vas deferens: correlation of response pattern to noradrenaline and histological structure. Eur. J. Pharmacol. 273:1995;25-34.
4. Amobi N.I.B., Smith I.C.H. Differential inhibition in the human vas deferens by phenoxybenzamine; a possible mechanism for its contraceptive action. J. Reprod. Fertil. 103:1995;215-221.
5. Anton P.G., McGrath J.C. Further evidence for adrenergic transmission in the human vas deferens. J. Physiol. 273:1977;45-55.
6. Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother. 14:1959;48-58.
7. Batra S.K. Sperm transport through vas deferens: review of hypotheses and suggestion for a quantitative model. Fertil. Steril. 25:1974;186-202.
8. Birmingham A.T. The human vas deferens: its response to electrical stimulation and to drugs. Br. J. Pharmacol. 34:1968;692P.
9. 1B-adrenoceptor mediating contraction of the rat spleen. Br. J. Pharmacol. 115:1995;467-475.
10. 1-adrenoceptors of the rat vas deferens and spleen. Br. J. Pharmacol. 116:1995;205P.
11. 1-adrenoceptor. Br. J. Pharmacol. 119:1996;1093-1110.
12. Daniel E.E., Low A.M., Gaspar V., Lu-Chao H., Green J., Akrong J., Duerksen S., Soyka C., Chen C.K., Boyd J., Kwan C.Y. Unusual α-adrenoceptor subtype in canine saphenous vein: comparison to mesenteric vein. Br. J. Pharmacol. 117:1996;1535-1543.
13. 1D-adrenoceptor subtype in rat myocardium, aorta and other tissues. Br. J. Pharmacol. 119:1996;269-276.
14. 1-adrenoceptor subtypes in rat tissues Pharmacol. Commun. 3:1993;323-332.
15. 1-Adrenoceptor classification: sharpening Occam's razor. TIPs. 15:1994;167-170.
16. 1-adrenoceptor classification. Br. J. Pharmacol. 121:1997;1127-1135.
17. 1c subtype. Mol. Pharmacol. 45:1994;703-708.
18. 1A-Adrenoceptor mediated contractile responses of the human vas deferens. Br. J. Pharmacol. 116:1995;1605-1610.
19. 2+ in smooth muscle. Nature. 329:1987;333-335.
20. 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery. Br. J. Pharmacol. 113:1994;723-728.
21. Hedlund H., Anderson K.-E., Larsson B. Effects of drugs interacting with adrenoceptors and muscarinic receptors in the epididymal and prostatic parts of the human vas deferens. J. Auton. Pharmacol. 5:1985;261-270.
22. Hieble J.P., Bond R.A. New directions in adrenoceptor pharmacology. TiPs. 15:1994;397-399.
23. 1-adrenoceptors: consensus update. Pharmacol. Rev. 47:1995;267-270.
24. 1c-adrenoceptor splice variants. FEBS Lett. 363:1995;256-260.
25. 1-adrenoceptor antagonist R-(-)-YM12617 on isolated human erectile tissue and vas deferens. Eur. J. Pharmacol. 186:1990;87-93.
26. Homonnai Z.T., Shilon M., Paz G.F. Phenoxybenzamine: an effective male contraceptive pill. Contraception. 29:1984;479-489.
27. 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens. Br. J. Pharmacol. 111:1994;1003-1008.
28. 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br. J. Pharmacol. 115:1995;981-986.
29. 1 adrenoceptors: binding, functional and in vivo studies. Br. J. Pharmacol. 118:1996;871-878.
30. 1B-adrenoceptor mediated components in the tension response of the rat vas deferens to electrical field stimulation. Br. J. Pharmacol. 105:1992;727-731.
31. 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101. Mol. Pharmacol. 33:1988;509-514.
32. 1-adrenoceptors involved in noradrenaline-induced contractions of rat thoracic aorta and dog carotid artery. Jpn. J. Pharmacol. 57:1991;535-544.
33. 1-adrenoceptor subtypes in the human prostate: functional and binding studies. Br. J. Urol. 74:1994;572-578.
34. 1D-adrenoceptor subtypes. Br. J. Pharmacol. 120:1997;231-238.
35. 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies. Br. J. Pharmacol. 107:1992;697-704.
36. 1-adrenoceptors in mammalian aortae: subclassification based on chlorethylclonidine, WB 4101 and nifedipine. J. Vasc. Res. 29:1992;33-40.
37. 1-adrenoceptor subtypes in rabbit thoracic aorta. Br. J. Pharmacol. 108:1993;1071-1076.
38. 1-adrenoceptor activation in the bisected rat vas deferens. Br. J. Pharmacol. 102:1991;439-445.
39. 1B-adrenoceptors. Eur. J. Pharmacol. 238:1993;407-410.
40. 2+ signalling mechanism and plays a different physiological role. Mol. Pharmacol. 38:1990;725-726.
41. 1B-adrenoceptor subtype. Br. J. Pharmacol. 114:1995;745-750.
42. Tian W.-N., Gupta S., Deth R.C. Species differences in chlorethylclonidine antagonism at vascular alpha-1 adrenergic receptors. J. Pharmacol. Exp. Ther. 253:1990;877-883.